Artiva Biotherapeutics Inc

Artiva Biotherapeutics Inc

ARTV - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$198.22M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Artiva Biotherapeutics IncArtiva Biotherapeutics Inc-1.3--31%--
$4.00

Target Price by Analysts

0.2% downsideArtiva Biotherapeutics Target Price DetailsTarget Price
$0.64

Current Fair Value

83.9% downside

Overvalued by 83.9% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$198.22 Million
Enterprise Value$146.16 Million
Earnings per Share$-3.43
Beta2.41
Outstanding Shares51,202,741

Return

Return on Equity-30.59%ROE
Return on Assets-28.61%
Return on Invested Capital-30.74%

Valuation & Multiples

P/E Ratio-1.34P/E Ratio
PEG-3.96PEG
Price to Sales-Price to Sales
Price to Book Ratio0.67Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-1.46
Enterprise Value to Net Income-2
Total Debt to Enterprise0.06
Debt to Equity0.03Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 11, 2026
EPS Estimate
-$0.54
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
March 9, 2027
EPS Estimate
-$0.56
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %2.90%▼ 99.57%
Total Invested$8.15M▼ 97.92%
Investors Holding22▼ 52.00%

About Artiva Biotherapeutics Inc

Artiva Biotherapeutics Insider Information FAQ

Stockcircle shows 19 open-market insider purchases and 21 open-market insider sales for Artiva Biotherapeutics in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.